Cell Reprogramming & Therapeutics

Business Services · Wisconsin, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

10437 W Innovation Dr Ste 321, Wauwatosa...

Phone Number

(414) 238-5067

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Cell Reprogramming & Therapeutics

Cell Reprogramming & Therapeutics LLC is a biotech company specializing in the development and commercialization of cell-based technologies aimed at treating diseases of the central nervous system. Their focus includes creating cellular models and therapeutics for various neurological disorders such as brain and spinal cord injuries, stroke, Parkinson's, Alzheimer's, ALS, Huntington's disease, and brain malignancies. The company is at the forefront of a new revolution in biomedicine, utilizing microbial and human cells as therapeutic engines. With recent advances in cell reprogramming technologies, they are paving the way for innovative cell-based therapies and regenerative medicine.Explore more
Cell Reprogramming & Therapeutics's Social MediaPopular SearchesCell Reprogramming & Therapeutics LLCReprogramming & Therapeutics LLCllcCell Reprogramming & Therapeutics LLCSIC Code 87,873NAICS Code 54,541Show more

Cell Reprogramming & Therapeutics Org Chart

BC
United States flag for contact location.

President & Chief Executive Officer

PhoneEmail
AA
United States flag for contact location.

Chief Scientific Officer, Founder

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Cell Reprogramming & Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Cell Reprogramming & Therapeutics

Compare insights from companies similar to Cell Reprogramming & Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Cell Reprogramming & Ther...

<$5M
1-10
Private
-
2013
BC
Brian CurryPresident & CEO
$10.4M
11-50
Private
$8.8M
2013
DB
David BurkeManager, Human Resources
$5.3M
11-50
Public
$43.7M
2007
Jonathan Doyle, Chief Financial Officer at Cognition Therapeutics
Jonathan DoyleChief Financial Officer
<$5M
11-50
Private
<$5M
2005
SB
Steven BorstPresident, CEO and Chairman of the Board
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Cell Reprogramming & Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Cell Reprogramming & Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cell Reprogramming & Therapeutics.

Cell Reprogramming & Therapeutics Tech Stack

A closer look at the technologies used by Cell Reprogramming & Therapeutics

Top Business Services Companies

Frequently Asked Questions Regarding Cell Reprogramming & Therapeutics

What is Cell Reprogramming & Therapeutics's official website?
Cell Reprogramming & Therapeutics's official website is www.cellrtherapeutics.com
What is Cell Reprogramming & Therapeutics's Revenue?
Cell Reprogramming & Therapeutics's revenue is <$5 Million
What is Cell Reprogramming & Therapeutics's SIC code?
Cell Reprogramming & Therapeutics's SIC: 87,873
What is Cell Reprogramming & Therapeutics's NAICS code?
Cell Reprogramming & Therapeutics's NAICS: 54,541
How many employees does Cell Reprogramming & Therapeutics have?
Cell Reprogramming & Therapeutics has 1-10 employees
What industry does Cell Reprogramming & Therapeutics belong to?
Cell Reprogramming & Therapeutics is in the industry of: Business Services, Research & Development
What is Cell Reprogramming & Therapeutics competition?
Cell Reprogramming & Therapeutics top competitors include: Q Therapeutics, Wernig Laboratory, Axol Bioscience, Convelo Therapeutics
What technology does Cell Reprogramming & Therapeutics use?
Some of the popular technologies that Cell Reprogramming & Therapeutics uses are: GoCentral, YouTube, Sched, Microsoft 365
How do I contact Cell Reprogramming & Therapeutics?
Cell Reprogramming & Therapeutics contact info: Phone number: (414) 238-5067 Website: www.cellrtherapeutics.com
What does Cell Reprogramming & Therapeutics do?

Cell Reprogramming & Therapeutics LLC is a biotech company specializing in the development and commercialization of cell-based technologies aimed at treating diseases of the central nervous system. Their focus includes creating cellular models and therapeutics for various neurological disorders such as brain and spinal cord injuries, stroke, Parkin... son's, Alzheimer's, ALS, Huntington's disease, and brain malignancies. The company is at the forefront of a new revolution in biomedicine, utilizing microbial and human cells as therapeutic engines. With recent advances in cell reprogramming technologies, they are paving the way for innovative cell-based therapies and regenerative medicine.Read More

What are Cell Reprogramming & Therapeutics social media links?
Cell Reprogramming & Therapeutics Linkedin page
Is Cell Reprogramming & Therapeutics a public company?
Cell Reprogramming & Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Cell Reprogramming & Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.